Filing Flows › MiniMed Group (MMED) › R&D spending
MiniMed Group (MMED) R&D spending by quarter
MiniMed Group's R&D spending was $115M in Q2 2026 (second quarter 2026), +16% from Q1 2026. Over the last 3 quarters it ranged from $99.0M (Q1 2026) to $115M (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $115M | +16% | — |
| Q1 2026 | $99.0M | -13% | — |
| Q1 2026 | $114M | — | — |
Q2 2026 at a glance
MiniMed Group, Q2 2026: revenue $843M (+17% year over year), operating margin 0.6%, net earnings $0, operating cash flow −$49.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is MiniMed Group's R&D spending?
MiniMed Group's R&D spending was $115M in Q2 2026 (second quarter 2026), +16% from Q1 2026.
How has MiniMed Group's R&D spending changed?
Over the last 3 quarters it ranged from $99.0M (Q1 2026) to $115M (Q2 2026).